Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of GW685698X in Persistent Asthma
NCT00398645Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2006
- Primary completion
- Aug 2007
- Modality
- Orthosteric Ligands
- Countries
- 16
01
Overview
Phase 2, randomised, double-blind trial of fluticasone in asthma (6 arms), sponsored by GSK. Primary endpoint: Mean change from baseline in trough forced expiratory volume in one second (FEV1) at 8 weeks. Started Nov 2006; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00398645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398645.